China Resources Pharmaceutical Group (CR Pharma) has launched its Hong Kong initial public offering. The transaction has been eagerly awaited by investors because of its size and analyst expectations that the listed stock should perform better than other recent IPOs.
¬ Haymarket Media Limited. All rights reserved.
